Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v3-EN
Language English English
Date Updated 2019-02-08 2019-01-18
Drug Identification Number 02427192 02427192
Brand name PRIVA-CETIRIZINE PRIVA-CETIRIZINE
Common or Proper name CETIRIZINE CETIRIZINE
Company Name PHARMAPAR INC PHARMAPAR INC
Ingredients CETIRIZINE HYDROCHLORIDE CETIRIZINE HYDROCHLORIDE
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code R06AE R06AE
ATC description ANTIHISTAMINES FOR SYSTEMIC USE ANTIHISTAMINES FOR SYSTEMIC USE
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date 2017-12-08 2017-12-08
Actual start date 2017-12-08 2017-12-08
Estimated end date 2019-02-08 2019-02-21
Actual end date 2019-02-07
Shortage status Resolved Actual shortage
Company comments
Health Canada comments